{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T22:07:15Z","timestamp":1792966035168,"version":"4.5.0"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jsbmb.2021.105876","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T11:09:29Z","timestamp":1616065769000},"page":"105876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER+ breast cancer cells: Impact on aromatase and steroid receptors"],"prefix":"10.1016","volume":"210","author":[{"given":"Cristina","family":"Amaral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien Marc","family":"Trouille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Ferreira","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Correia-da-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e9rcia","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jsbmb.2021.105876_bib0005","doi-asserted-by":"crossref","first-page":"R283","DOI":"10.1530\/ERC-17-0425","article-title":"Acquired-resistance to aromatase inhibitors: where we stand!","volume":"25","author":"Augusto","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/omi.2010.0097","article-title":"An \"omics\" approach to determine the mechanisms of acquired aromatase inhibitor resistance","volume":"15","author":"Chen","year":"2011","journal-title":"OMICS"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jsbmb.2015.07.018","article-title":"Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and -resistant breast cancer cells","volume":"161","author":"Chan","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0020","doi-asserted-by":"crossref","first-page":"113989","DOI":"10.1016\/j.bcp.2020.113989","article-title":"Estrogen receptor-positive (ER+) breast cancer treatment: are multi-target compounds the next promising approach?","volume":"177","author":"Almeida","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2016.03.019","article-title":"Unravelling exemestane: from biology to clinical prospects","volume":"163","author":"Sobral","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0030","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/annonc\/mdy192","article-title":"4th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 4)dagger","volume":"29","author":"Cardoso","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0035","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.annonc.2020.09.010","article-title":"5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)","volume":"31","author":"Cardoso","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/bjc.2016.405","article-title":"Cotargeting of CYP-19 (aromatase) and emerging, pivotal signalling pathways in metastatic breast cancer","volume":"116","author":"Daldorff","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0045","series-title":"Handbook of cannabis","author":"Pertwee","year":"2014"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0050","first-page":"XII, 475","article-title":"Endocannabinoids","volume":"231","author":"Pertwee","year":"2015"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/112_2017_3","article-title":"Cannabinoids as modulators of cell death: clinical applications and future directions","volume":"173","author":"Fonseca","year":"2017","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.prostaglandins.2013.02.002","article-title":"Endogenous cannabinoids revisited: a biochemistry perspective","volume":"102\u2013103","author":"Fonseca","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0065","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0070","first-page":"103","article-title":"Molecular targets of the phytocannabinoids: a complex picture","volume":"103","author":"Morales","year":"2017","journal-title":"Prog. Chem. Org. Nat. Prod."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0075","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bjp.0707481","article-title":"Novel cannabinoid receptors","volume":"152","author":"Brown","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0080","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ctrv.2012.06.005","article-title":"Cannabinoids: a new hope for breast cancer therapy?","volume":"38","author":"Caffarel","year":"2012","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0085","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1080\/13543784.2016.1236913","article-title":"Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas","volume":"25","author":"Fraguas-Sanchez","year":"2016","journal-title":"Expert Opin. Invest. Drug"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0090","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.18632\/oncotarget.2233","article-title":"Cannabinoids as therapeutic agents in cancer: current status and future implications","volume":"5","author":"Chakravarti","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0095","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nrc3247","article-title":"Towards the use of cannabinoids as antitumour agents","volume":"12","author":"Velasco","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0100","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.3747\/co.23.3080","article-title":"Anticancer mechanisms of cannabinoids","volume":"23","author":"Velasco","year":"2016","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0105","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/cam4.1312","article-title":"The current state and future perspectives of cannabinoids in cancer biology","volume":"7","author":"Sledzinski","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2017.02.041","article-title":"Cannabidiol: state of the art and new challenges for therapeutic applications","volume":"175","author":"Pisanti","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0115","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s40265-018-0996-1","article-title":"Medical use of cannabinoids","volume":"78","author":"Fraguas-Sanchez","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0120","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/bph.14426","article-title":"Anti-tumour actions of cannabinoids","volume":"176","author":"Hinz","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.jsbmb.2021.105876_bib0125","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.3390\/ijms20071673","article-title":"Future aspects for cannabinoids in breast cancer therapy","volume":"20","author":"Kiskova","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0130","first-page":"301","article-title":"Critical appraisal of the potential use of cannabinoids in cancer management","volume":"5","author":"Cridge","year":"2013","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.jsbmb.2021.105876_bib0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40122-019-0114-4","article-title":"An update of current cannabis-based pharmaceuticals in pain medicine","volume":"8","author":"Urits","year":"2019","journal-title":"Pain Ther."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0140","doi-asserted-by":"crossref","first-page":"104822","DOI":"10.1016\/j.phrs.2020.104822","article-title":"Cannabis sativa: much more beyond \u03949-tetrahydrocannabinol","volume":"157","author":"Alves","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0145","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: a systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0150","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1158\/0008-5472.CAN-05-4566","article-title":"Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation","volume":"66","author":"Caffarel","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0155","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1073\/pnas.95.14.8375","article-title":"The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation","volume":"95","author":"De Petrocellis","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0160","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1124\/jpet.106.105247","article-title":"Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma","volume":"318","author":"Ligresti","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0165","doi-asserted-by":"crossref","first-page":"6076","DOI":"10.1016\/j.febslet.2006.09.074","article-title":"Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells","volume":"580","author":"Laezza","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0170","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1158\/1535-7163.MCT-10-1100","article-title":"Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy","volume":"10","author":"Shrivastava","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0175","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1476-4598-9-196","article-title":"Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition","volume":"9","author":"Caffarel","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0180","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.yexcr.2005.10.024","article-title":"Anandamide inhibits adhesion and migration of breast cancer cells","volume":"312","author":"Grimaldi","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0185","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.breast.2018.06.009","article-title":"Novel mechanism of cannabidiol-induced apoptosis in breast cancer cell lines","volume":"41","author":"Sultan","year":"2018","journal-title":"Breast"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0190","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1158\/1535-7163.MCT-07-0371","article-title":"Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells","volume":"6","author":"McAllister","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0195","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bcp.2018.06.025","article-title":"Appraising the \u201centourage effect\u201d: antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer","volume":"157","author":"Blasco-Benito","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0200","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.molonc.2014.12.010","article-title":"Modulation of the tumor microenvironment and inhibition of EGF\/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer","volume":"9","author":"Elbaz","year":"2015","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0205","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.4049\/jimmunol.174.6.3281","article-title":"Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response","volume":"174","author":"McKallip","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0210","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tox.2007.12.019","article-title":"Delta(9)-Tetrahydrocannabinol enhances MCF-7 cell proliferation via cannabinoid receptor-independent signaling","volume":"245","author":"Takeda","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0215","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.tox.2004.08.005","article-title":"Marijuana extracts possess the effects like the endocrine disrupting chemicals","volume":"206","author":"Watanabe","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0220","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/13543784.2019.1561859","article-title":"Cannabis for cancer - illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology","volume":"28","author":"Turgeman","year":"2019","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0225","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.21873\/anticanres.12924","article-title":"Report of objective clinical responses of cancer patients to pharmaceutical-grade synthetic cannabidiol","volume":"38","author":"Kenyon","year":"2018","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.jsbmb.2021.105876_bib0230","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3390\/cancers12030525","article-title":"Cannabinoids and hormone receptor-positive breast cancer treatment","volume":"12","author":"Dobovisek","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0235","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1158\/1535-7163.MCT-09-0448","article-title":"Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer","volume":"8","author":"Qamri","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0240","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10555-011-9318-8","article-title":"Cannabinoids, endocannabinoids, and cancer","volume":"30","author":"Hermanson","year":"2011","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0245","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cell.2009.11.027","article-title":"Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis","volume":"140","author":"Nomura","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0250","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1111\/bph.14331","article-title":"Insights into the effects of the endocannabinoid system in cancer: a review","volume":"175","author":"Fraguas-Sanchez","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0255","doi-asserted-by":"crossref","first-page":"djv077","DOI":"10.1093\/jnci\/djv077","article-title":"Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer","volume":"107","author":"Perez-Gomez","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0260","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bbrc.2013.10.057","article-title":"CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen","volume":"441","author":"Prather","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0265","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bbrc.2013.11.071","article-title":"CB2 cannabinoid receptor is a novel target for third-generation selective estrogen receptor modulators bazedoxifene and lasofoxifene","volume":"443","author":"Kumar","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0270","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3389\/fphar.2016.00503","article-title":"Selective estrogen receptor modulators: cannabinoid receptor inverse agonists with differential CB1 and CB2 selectivity","volume":"7","author":"Franks","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.jsbmb.2021.105876_bib0275","doi-asserted-by":"crossref","first-page":"158512","DOI":"10.1016\/j.bbalip.2019.08.008","article-title":"Anandamide targets aromatase: a breakthrough on human decidualization","volume":"1864","author":"Almada","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0280","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.reprotox.2020.01.003","article-title":"Cannabidiol (CBD) but not tetrahydrocannabinol (THC) dysregulate in vitro decidualization of human endometrial stromal cells by disruption of estrogen signaling","volume":"93","author":"Almada","year":"2020","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0285","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1158\/1541-7786.MCR-04-0122","article-title":"Letrozole-, anastrozole-, and tamoxifen-responsive genes in MCF-7aro cells: a microarray approach","volume":"3","author":"Itoh","year":"2005","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0290","first-page":"6949","article-title":"Stable expression of human aromatase complementary DNA in mammalian cells: a useful system for aromatase inhibitor screening","volume":"50","author":"Zhou","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0295","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0960-0760(97)00068-X","article-title":"Autocrine and paracrine actions of breast tumor aromatase. A three-dimensional cell culture study involving aromatase transfected MCF-7 and T-47D cells","volume":"63","author":"Sun","year":"1997","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042398","article-title":"Apoptosis and autophagy in breast cancer cells following exemestane treatment","volume":"7","author":"Amaral","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0305","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jsbmb.2017.04.002","article-title":"Anti-tumor efficacy of new 7alpha-substituted androstanes as aromatase inhibitors in hormone-sensitive and resistant breast cancer cells","volume":"171","author":"Amaral","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0310","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jsbmb.2012.12.017","article-title":"Effects of steroidal aromatase inhibitors on sensitive and resistant breast cancer cells: aromatase inhibition and autophagy","volume":"135","author":"Amaral","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0315","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.biocel.2015.10.024","article-title":"Exemestane metabolites suppress growth of estrogen receptor-positive breast cancer cells by inducing apoptosis and autophagy: a comparative study with exemestane","volume":"69","author":"Amaral","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0320","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13105-018-0611-7","article-title":"Cannabinoid-induced cell death in endometrial cancer cells: involvement of TRPV1 receptors in apoptosis","volume":"74","author":"Fonseca","year":"2018","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0325","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jsbmb.2018.05.006","article-title":"Hormone-dependent breast cancer: targeting autophagy and PI3K overcomes exemestane-acquired resistance","volume":"183","author":"Amaral","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0330","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1016\/S0021-9258(20)79735-8","article-title":"Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione","volume":"249","author":"Thompson","year":"1974","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105486","article-title":"Effects of new C6-substituted steroidal aromatase inhibitors in hormone-sensitive breast cancer cells: cell death mechanisms and modulation of estrogen and androgen receptors","volume":"195","author":"Augusto","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0340","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.biochi.2020.11.023","article-title":"Discovery of a multi-target compound for estrogen receptor-positive (ER(+)) breast cancer: involvement of aromatase and ERs","volume":"181","author":"Almeida","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0345","doi-asserted-by":"crossref","first-page":"10281","DOI":"10.1158\/0008-5472.CAN-06-2134","article-title":"Aromatase destabilizer: novel action of exemestane, a food and drug administration-approved aromatase inhibitor","volume":"66","author":"Wang","year":"2006","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.jsbmb.2021.105876_bib0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.165661","article-title":"The potential clinical benefit of targeting androgen receptor (AR) in estrogen-receptor positive breast cancer cells treated with Exemestane","volume":"1866","author":"Amaral","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0355","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ejmech.2014.09.074","article-title":"Exemestane metabolites: synthesis, stereochemical elucidation, biochemical activity and anti-proliferative effects in a hormone-dependent breast cancer cell line","volume":"87","author":"Varela","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"Suppl. 1","key":"10.1016\/j.jsbmb.2021.105876_bib0360","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.3816\/CBC.2005.s.008","article-title":"The history and mechanism of action of fulvestrant","volume":"6","author":"Carlson","year":"2005","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0365","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1021\/jm049631k","article-title":"Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity","volume":"47","author":"Compton","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0370","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1210\/en.2008-1355","article-title":"Estrogen receptor-beta agonist diarylpropionitrile: biological activities of R- and S-enantiomers on behavior and hormonal response to stress","volume":"150","author":"Weiser","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0375","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ctrv.2017.09.006","article-title":"Androgen receptor in estrogen receptor positive breast cancer: beyond expression","volume":"61","author":"Basile","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0380","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1158\/1078-0432.CCR-12-3327","article-title":"Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic breast cancer","volume":"19","author":"Gucalp","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0385","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1186\/bcr3599","article-title":"Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide","volume":"16","author":"Cochrane","year":"2014","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0390","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3389\/fphar.2019.01124","article-title":"Antitumor activity of abnormal cannabidiol and its analog O-1602 in taxol-resistant preclinical models of breast cancer","volume":"10","author":"Tomko","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0395","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1038\/onc.2008.145","article-title":"JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells","volume":"27","author":"Caffarel","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0400","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.prostaglandins.2015.12.006","article-title":"Cannabinoid-induced autophagy: protective or death role?","volume":"122","author":"Costa","year":"2016","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0405","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/cdd.2009.33","article-title":"Life and death partners: apoptosis, autophagy and the cross-talk between them","volume":"16","author":"Eisenberg-Lerner","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0410","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s10495-008-0307-5","article-title":"The paradox of autophagy and its implication in cancer etiology and therapy","volume":"14","author":"Eisenberg-Lerner","year":"2009","journal-title":"Apoptosis"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0415","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/1389200217666151210142051","article-title":"Cannabinoids and cytochrome P450 interactions","volume":"17","author":"Zendulka","year":"2016","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0420","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000179858","article-title":"The suppressive effect of delta-1-tetrahydrocannabinol on the steroidogenic activity of rat granulosa cells in culture","volume":"19","author":"Lewysohn","year":"1984","journal-title":"Horm. Res."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0425","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1158\/0008-5472.CAN-03-2446","article-title":"Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest","volume":"64","author":"Paruthiyil","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0430","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/bcr1667","article-title":"Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer","volume":"9","author":"Lin","year":"2007","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0435","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0006-2952(96)00659-4","article-title":"Failure of cannabinoid compounds to stimulate estrogen receptors","volume":"53","author":"Ruh","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0440","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1021\/tx4000446","article-title":"Delta(9)-Tetrahydrocannabinol disrupts estrogen-signaling through up-regulation of estrogen receptor beta (ERbeta)","volume":"26","author":"Takeda","year":"2013","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0445","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.2174\/138161212800626139","article-title":"Estrogen receptor beta in cancer: an attractive target for therapy","volume":"18","author":"Gallo","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0450","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tips.2016.10.006","article-title":"Estrogen receptor beta as a pharmaceutical target","volume":"38","author":"Warner","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0455","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/jcp.2003.008599","article-title":"The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer","volume":"57","author":"Nakopoulou","year":"2004","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060889","article-title":"Fulvestrant-induced cell death and proteasomal degradation of estrogen receptor alpha protein in MCF-7 cells require the CSK c-Src tyrosine kinase","volume":"8","author":"Yeh","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2021.105876_bib0465","doi-asserted-by":"crossref","first-page":"9607","DOI":"10.1074\/jbc.M510809200","article-title":"Fulvestrant (ICI 182,780)-dependent interacting proteins mediate immobilization and degradation of estrogen receptor-alpha","volume":"281","author":"Long","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2021.105876_bib0470","first-page":"85","article-title":"Delta(9)-tetrahydrocannabinol inhibits 17beta-estradiol-induced proliferation and fails to activate androgen and estrogen receptors in MCF7 human breast cancer cells","volume":"28","author":"von Bueren","year":"2008","journal-title":"Anticancer Res."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076021000698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076021000698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:08:48Z","timestamp":1760746128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076021000698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":94,"alternative-id":["S0960076021000698"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2021.105876","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER+ breast cancer cells: Impact on aromatase and steroid receptors","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2021.105876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105876"}}